chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid fingers - left ring finger swollen and black and blue (with a bump) - from base of the finger to the joint as of 4pm on 2/24.  On 2/25 in the morning the black and blue has extended beyond the knuckle toward the end of the finger but only about 1/4" beyond the knuckle. Right hand, middle finger, black and blue between the knuckle nearest the hand and the knuckle nearest the finger tip.  No swelling.  This was noticed about 9pm on 2/24.   Covid Toes - possibly - red bumps on toes same toe, both feet, red.  Toes next to pinky toe.
The day after receiving Polio vaccine, patient developed a fever of 102.8, was crying a lot, and had a red lump at the vaccine site.  She didn't sleep or nurse well.  The fever continued for about 36 hours then slowly went away.
Nausea; Dizziness; Vomiting; Fever; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot Number: EL1283), via an unspecified route of administration on 21Jan2021 13:00 (at the age of 73-years-old) as a single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included unspecified medications. On 21Jan2021, consumer stated, "I got the Pfizer vaccine on Thursday (21Jan2021) at 13:00 and I started having at 13:23 I started having nausea and a little dizziness and then I have had nausea and vomiting twice but nausea was constant. On an unspecified date in Jan2021, the patient had fever. Consumer stated, I am kind of dizzy. So, I got to walk slow. Therapeutic measures were taken as a result of events included pepcid for nausea and Tylenol for fever. The consumer stated, "I am really having side effects. I thought it is going way. And I wanted to know how long I would have side effects." The outcome of the events was not recovered.
26Jun90 pt vax;  04Jul90 devel rash starting on feet which progressed upwards to shoulders.  05Jul90 devel joint pain & gen itching.  Tx w/ DPH.  06Jul90 rash resolved but itching & pain persisted.
Second shot.  Woke up at 11:45 pm (Feb. 25) with fever and chills.  Took a Tylenol after 45 minutes and went back to sleep.  Next morning  (Feb. 26) at 9:00 am had fever of 100.3, was fatigued, and had little appetite.  Took another Tylenol.  Sat around all day.  By evening was feeling slightly better.  Next morning had no fever, most of appetite was back, and felt slightly fatigued, but functioned normally, i.e., took a 2-mile walk, as usual.
had almost every side effect they said could happen/The crappy week we had; This case was reported by a consumer and described the occurrence of malaise in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced malaise. On an unknown date, the outcome of the malaise was recovered/resolved.   It was unknown if the reporter considered the malaise to be related to Shingles vaccine.   Additional details were reported as follows: This case was reported by the patients wife. The patients had almost every side effect they said could happen. The patients wife stated crappy week they had was much better than what her dad went through when he had shingles.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR227914:Same reporter
Information has been received from a nurse concerning a 29 old female patient who on 11-OCT-2007 was vaccinated with a dose of PNEUMOVAX 23 lot 3 658447/1132U. On 11-OCT-2007 the patient developed "cellulitis" after getting the PNEUMOVAX 23. No other information was available. The outcome was unknown. The physician has requested A lot check for PNEUMOVAX 23 #658447/1132U. Additional information has been requested.
Axillary area is swollen; Almost fainted; Fever; Fast heart beat; This spontaneous case was reported by an other health care professional and describes the occurrence of TACHYCARDIA (Fast heart beat), AXILLARY MASS (Axillary area is swollen), DIZZINESS (Almost fainted) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Penicillin allergy.    On 02-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced TACHYCARDIA (Fast heart beat) and PYREXIA (Fever). On 03-Sep-2021, the patient experienced AXILLARY MASS (Axillary area is swollen) and DIZZINESS (Almost fainted). At the time of the report, TACHYCARDIA (Fast heart beat), AXILLARY MASS (Axillary area is swollen), DIZZINESS (Almost fainted) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient took OTC pain medication.
Patient was at clinic for routine visit to review labs and receive vaccinations. Swelling and erythema was still present 2 days after injection but was reduced. Treated with unknown doses of diphenhydramine and acetaminophen. Also given a prescription for KEFLEX 500 TID 7d to start if any worsening, but hold if continues to improve. Antibiotic not filled. It is unknown if it was filled at another pharmacy. Treatment: Diphenhydramine, Acetaminophen.
Severe headaches; Dizziness; Tired all the time; Muscle weakness; muscle pain all day long; some chest tightness; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 22Apr2021 at 08:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included Monoclonal Gammopathy of Undetermined Significance (MGUS), neuropathy, myasthenia gravis, high cholesterol, high blood pressure, hypoglycemia, gastroesophageal reflux disease (GERD) and cataracts. The patient had unspecified allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 22:30, the patient experienced severe headaches, dizziness, was tired all the time, muscle weakness and pain all day long and some chest tightness. The patient stated that, the headaches were so bad that patient could not think straight. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent unspecified lab tests on an unknown date and the results were unknown. The clinical outcome of the events severe headaches, dizziness, tired all the time, muscle weakness and pain all day long and some chest tightness were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
I now I got a COVID from a party. My symptoms started 2 day after the party. I was weak with body ache. I tested at home and was negative. I tested two days later and was positive. During the sickness I took day quill and night quill.  I developed  hives and heart complications, post viral reaction.  I take prednisone for the hives.  And I take hydro steroids' for the hives.
This spontaneous report was received from a nurse refers to a patient of unknown age. On 11-JUL-2016, the patient was inadvertently vaccinated with an expired dose of GARDASIL lot # K008335, 23-JUN-2016 intramuscular. No adverse effect was reported. Additional information has been requested.
Narrative:  The patient received his Janssen Vaccine at facility on April 10th and then on April 30th he presents to the private Hospital w/ acute stroke symptoms. In reviewing the information from hospital they determine it was a sagittal sinus thrombus (venous thrombus). He is eventually found to have coagulopathy issues - low antithrombin III and abnormal factor V leiden. He transferred to another facility 4-30-21 and developed a worsening of his stroke symptoms. Repeat imaging determined his initial venous infarction progressed to a hemorrhagic conversion. He also developed bilateral DVT clots and a spontaneous pneumothorax.
muscle fatigue, shortness of breath, heart rate spikes, chest pain, dizziness, headache, nausea
Coughing, C/O back of throat burning.  Had H1N1 shot 3.5 hours ago.  Also c/o trouble swallowing.  B/P 182/106 HR 82.  Epinephrine 0.3 cc to lateral rt. thigh.  12:30 PM BP 180/86 HR 100 T 98.4.  EMS called.  12:40 person feeling better. Throat burning going away.
Suddent onset of tinnitus in the left ear.  Has not abated.  Only reporting because my biological brother (1 1/2 years younger) also had the onset of tinnitus after receiving the vaccine (Pfiser).
2 weeks later the urgent care facility told him he was positive to Covid; 2 weeks later the urgent care facility told him he was positive to Covid; Wasn't feeling well after 1st dose; This is a spontaneous report from a contactable consumer (patient). A 53-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection) via an unspecified route of administration on 11Mar2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, he took 1st vaccine on 11Mar2021 and scheduled for the 2nd on 01Apr2021. Took 2 covid test on 09Mar2021 and came back negative. Wasn't feeling well after 1st dose. 2 weeks later the urgent care facility told him he was positive to Covid and has to isolate for 10 days.   Information on the lot/batch number has been requested.
7/19 given HPV approximately 8/18 spotting daily x 2 wks; stopped x 5 days; approximately 9/10 restarted daily spotting (1 liner/day); 9/23 after few days increased d/c, 2-3 liners/day; 10/18 1-2 liners/day approximately x 1 wk already.
Approximately 16 hours after receiving  my third Pfizer shot, I was light headed and dizzy.  I passed out approximately 5 times.  I do not remember falling, I woke up on the floor.  I felt sweaty at that time also.  I got a fat lip from hitting the floor.
In first 24 hrs-mild redness, itching over course of 2 days redness increase with 6" by 5"-no fever no streaking redness, hot to touch pt will take BENADRYL and Ibuprofen and will ice arm.
A 54 yo female with a history of CKD, coronary artery disease, diabetes mellitus, and hypertension presents to the ED with complaints of SOB that began on 7/24. The patient states that she had an associated fever and cough as of yesterday. She reports that she is currently fully vaccinated against COVID-19. The SOB is constant, mild in severity, and has no known alleviating or exacerbating factors. The patient upon arrival to the ED had an oxygen saturation of 76%. The patient denies chest pain, vomiting, rash, or any to her acute symptoms.
pt recv vax 26JUN95 t102 x 2 days on 28JUN95 awoke w/red, pinpoint rash over entire body, t104; emesis (projectile) when given fluids; seen by MD then later in day seen again by MD for t105; took DPH & APAP;
This spontaneous case was reported by a consumer and describes the occurrence of PSORIATIC ARTHROPATHY (Psoriatic arthritis aggravated) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIATIC ARTHROPATHY (Psoriatic arthritis aggravated) (seriousness criterion medically significant). At the time of the report, PSORIATIC ARTHROPATHY (Psoriatic arthritis aggravated) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No concomitant medication information was reported. No treatment medication information was reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Company comment: This spontaneous case reported by a consumer, concerns an adult female patient of unknown age, with no relevant medical history reported, who experienced the unexpected, serious, medically significant event of PSORIATIC ARTHROPATHY (Psoriatic arthritis aggravated) unknown days after receiving the 1 dose of mRNA-1273 vaccine in the Covid 19 vaccination series. It was reported that on an unknown date, patient also took Adalimumab for Psoriatic Arthropathy, which could be considered as a confounder for the flare up. No further clinical information on other comorbidities, risk factors, symptoms, labs, diagnostics, concomitant medications and treatment details were available in the report. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report. Sender's Comments: This spontaneous case reported by a consumer, concerns an adult female patient of unknown age, with no relevant medical history reported, who experienced the unexpected, serious, medically significant event of PSORIATIC ARTHROPATHY (Psoriatic arthritis aggravated) unknown days after receiving the 1 dose of mRNA-1273 vaccine in the Covid 19 vaccination series. It was reported that on an unknown date, patient also took Adalimumab for Psoriatic Arthropathy, which could be considered as a confounder for the flare up. No further clinical information on other comorbidities, risk factors, symptoms, labs, diagnostics, concomitant medications and treatment details were available in the report. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.
Eve of vaccination - developed pruritis and erythema @ injection site.  - Erythema increase to 10cm x 4.5cm - Pt called Dr.  Dx "cellulitis." ? Treatment. - All was reported by patient
Fussy the evening of the vaccine 3 episodes vomiting the following day wetter more explosive stools. Discussion of incidental D vs DTaP vs AGE
2 Days following DTaP vaccine to right thigh. Area with induration of 8cm x 6cm. Center area positive for hematoma. Mild tenderness to touch. Temp 100.1 axillary possibly related to unk illness.
Patient presented to the counsel window saying he was having trouble swallowing after receiving a COVID-19 vaccine (Moderna). The patient stated he wanted me to call 911 so I called 911 and the technician called a "code" over the pager. I went with the patient back to the vaccine booth and got him to take a seat. The patient then stated that he had an allergy to cashews. I retrieved the emergency kit. I asked the patient if he wanted me to give him the epi pen and he said no. He asked if we would page his wife as well. I gave the patient some water while asking how he was breathing. He said it was just difficult to swallow. He said he didn't have any trouble breathing  but was noticeably shaking. Management came to check in and then went to wait for the ambulance to arrive. The patients wife also called 911 from his phone. While they were on the phone the EMTs showed up. They carried the patient out to the ambulance on the stretcher.
pt recv vax 27MAY97 & lab eval on 24JUN97 & 1SEP97 using IGA testing revealed a failure to seroconvert;
rash all over body that looks  like red dots; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (rash all over body that looks  like red dots) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced RASH ERYTHEMATOUS (rash all over body that looks  like red dots). At the time of the report, RASH ERYTHEMATOUS (rash all over body that looks  like red dots) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Red blotchy spots on arms, swelling of legs, face flushing.  Treated with PO Famotidine, Dexamethasone,  Epinephrine. Transferred to Utah Valley Hospital via ambulance for further observation.
Cold symptoms; Congestion and sneezing and some sinus drainage, I feel like I have cold; Sneezing, congestion and drainage like common cold.; Congestion and sneezing and some sinus drainage, I feel like I have cold; Sneezing, congestion and drainage like common cold.; Congestion and sneezing and some sinus drainage, I feel like I have cold; Sneezing, congestion and drainage like common cold.; This is a spontaneous report from a contactable consumer reporting for himself.   A 69-years-old male patient received bnt162b2 (BNT162B2; Lot # EL1283) vaccine , via an unspecified route of administration on 21Jan2021 08:30 at single dose for Covid-19 immunisation .  The patient medical history and concomitant medications were not reported.  The patient experienced cold symptoms  on 22Jan2021 with outcome of unknown , congestion and sneezing and some sinus drainage, i feel like i have cold on 22Jan2021 with outcome of unknown. The patient used nasal spry of fluticasone as a treatment.  Follow up information has been requested
I received the vaccine at 1:40 PM in my left arm. They had me wait 15 minutes for observation. 15 minutes later, I left feeling fine. I went back to work. Around 2:15 I started getting chills. I ignored it thinking that I was psyching myself into it thinking about the shot. But then the nausea began. I was at work and started feeling horrible. I started cramping in my stomach. I was alone at work, and then I started throwing up. It started at 3:40. I left work at 4:30 with the most body wracking chills and went to the emergency room. I was violently heaving at this point and they rushed me into a room where I received an IV drip of fluids and anti nausea medication. It wasn't until after the medication was administered that I felt better. I would say this was around 5 pm. They sent me home with an anti nausea medication. I was released to go home around 730-8 PM. I felt so much better after the medication was administered.
Received Smallpox vaccine on 2/24/03. Second week had left arm swelling with "pins and needles" feeling on inside of arm from wrist to shoulder. No temperature or lymphedema. Continues to have pain in arm.
Patient states that two hours after he received flu vaccine he started to urinate blood. He could not describe if he was a lot but he said it was "enough to notice." Patient also stated that he has had more burning and general pain throughout body; he says he is more forgetful, irritable, joint stiffness, fatigue and more frequent headaches. Patient did not continue to have visible blood in his urine. He did come in 5 days after he noticed blood in his urine and Provider ordered a urinalysis. No blood was found in urine sample results.
Clumsy falling on face then fever two days diarrhea and vomiting for 10 days I gave a fruit and veggies smoothie cleanse.
tested postive for covid-19 after 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested postive for covid-19 after 1st dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K02A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced COVID-19 (tested postive for covid-19 after 1st dose). On 16-Jan-2021, COVID-19 (tested postive for covid-19 after 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, Severe acute respiratory syndrome: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications used by the patient was not reported.   No Treatment details was provided.
Localized mottled erythema, non-itching, spreading across upper chest from both deltoids (injection sites).
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported. The reporter stated that because their facility has not been able to download the digital data logger, they have been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the State was made.  There had been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  Reporter stated that no adverse reactions were reported by any patients.
On 11/26/2022, I woke up feeling sick. I felt like I was starting a sinus infection. It continued through the day, and I developed a fever that afternoon. That night I had chills. Sunday was the same and I slept all day. Monday morning, I called the local clinic. I went in and was tested for COVID-19 and was positive. They sent me home and advised that I just rest because my symptoms were not severe. I asked about PAXLOVID, but she advised that I did not need it. By Wednesday, I was feeling a lot better.